SCHEMBL7897283

SCHEMBL7897283

CC(C)S(=O)(=O)NC1CCc2cc(Oc3cccc(CNS(C)(=O)=O)c3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 2/20 0.42
TRPV1 Q8NER1 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
PKM P14618 1/20 0.35
STS P08842 1/20 0.34
CYP19A1 P11511 1/20 0.34
PDE4A P27815 2/20 0.34
PDE4B Q07343 2/20 0.34
PDE4C Q08493 2/20 0.34
PDE4D Q08499 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7889347 0.82 GRIA2 (0.48) GRIA2SLC6A4PDE4APDE4BPDE4C
SCHEMBL11898486 0.82 GRIA2 (0.53) GRIA2
SCHEMBL7896398 0.82 GRIA2 (0.53) GRIA2
SCHEMBL11898573 0.79 GRIA2 (0.39) GRIA2STSPDE4APDE4BPDE4C
SCHEMBL7896364 0.78 PDE4A (0.42) GRIA2LMNASTSPDE4APDE4B
SCHEMBL7898009 0.78 GRIA2 (0.48) GRIA2LMNATP53THRBPDE4A
SCHEMBL7899290 0.74 GRIA2 (0.42) GRIA2TRPV1PDE4APDE4BPDE4C
SCHEMBL7899266 0.74 PDE4A (0.43) GRIA2TRPV1CYP19A1PDE4APDE4B
SCHEMBL7896164 0.73 GRIA2 (0.49) GRIA2TRPV1LMNAKDM4EALDH1A1
SCHEMBL7888226 0.73 GRIA2 (0.49) GRIA2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633237-B2 Indane derivatives MERCK SHARP & DOHME B.V. (NL) 2014-01-21 US disclosed
US-8633237-B2 Indane derivatives MERCK SHARP & DOHME B.V. (NL) 2014-01-21 US disclosed
US-20120202781-A1 INDANE DERIVATIVES MSD OSS B.V. (NL) 2012-08-09 US disclosed
US-20120202781-A1 INDANE DERIVATIVES MSD OSS B.V. (NL) 2012-08-09 US disclosed
WO-2010115952-A1 INDANE DERIVATIVES N.V. ORGANON (NL) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202781-A1 INDANE DERIVATIVES CHRNA5, CHRNA2, GRIK5 GRIA2 24/4885TRPV1 227/4885SLC6A2 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.